<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15365">Acetylsalicylic acid</z:chebi> (<z:chebi fb="37" ids="15365">ASA</z:chebi>) is neuroprotective through various pharmacological action sites </plain></SENT>
<SENT sid="1" pm="."><plain>We used a temporary middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) model in 56 Wistar rats to assess whether repeated <z:chebi fb="37" ids="15365">ASA</z:chebi> injections at 30 min, 6 h, 1, 2, 3, and 4 days after <z:hpo ids='HP_0001297'>stroke</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> are neuroprotective </plain></SENT>
<SENT sid="2" pm="."><plain>Animals were sacrificed 5 days after MCAO; <z:mpath ids='MPATH_124'>infarct</z:mpath> size was analyzed with 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining </plain></SENT>
<SENT sid="3" pm="."><plain>As compared to saline (164+/-13 mm(3), n=14), only repeated injections of 40 mg/kg <z:chebi fb="37" ids="15365">ASA</z:chebi> (79+/-18 mm(3), n=14, P=0.0029), but not of 20 mg/kg <z:chebi fb="37" ids="15365">ASA</z:chebi> (129+/-19 mm(3), n=15), reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume significantly </plain></SENT>
<SENT sid="4" pm="."><plain>No significant change was noted with 40 mg/kg <z:chebi fb="37" ids="15365">ASA</z:chebi> injected only once at 30 min after MCAO (117+/-16 mm(3), n=13) </plain></SENT>
</text></document>